Integrin {beta}3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC - Noh, K.-W., Sohn, I., Song, J.-Y., Shin, H.-T., Kim, Y.-J., Jung, K., Sung, M., Kim, M., An, S., Han, J., Lee, S.-H., Lee, M.-S., Choi, Y.-L. (The American Association for Cancer Research (AACR), 2018)
6327883
Keywords: WW-YZ